ALTE Stock Overview
A medical device company, provides technology for blood purification during extracorporeal treatment. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Alteco Medical AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.25 |
| 52 Week High | SEK 0.45 |
| 52 Week Low | SEK 0.089 |
| Beta | 0.10 |
| 1 Month Change | 0% |
| 3 Month Change | 53.37% |
| 1 Year Change | 20.19% |
| 3 Year Change | -70.02% |
| 5 Year Change | -76.08% |
| Change since IPO | -95.83% |
Recent News & Updates
Shareholder Returns
| ALTE | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 0% | -0.1% | 0.3% |
| 1Y | 20.2% | -0.04% | 13.5% |
Return vs Industry: ALTE exceeded the Swedish Medical Equipment industry which returned -0% over the past year.
Return vs Market: ALTE exceeded the Swedish Market which returned 13.5% over the past year.
Price Volatility
| ALTE volatility | |
|---|---|
| ALTE Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 12.2% |
| 10% least volatile stocks in SE Market | 3.3% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine ALTE's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 4 | n/a | www.altecomedical.com |
Alteco Medical AB, a medical device company, provides technology for blood purification during extracorporeal treatment. Its product portfolio includes Alteco LPS Adsorber, which removes endotoxin from the bloodstream. Alteco Medical AB was founded in 2002 and is based in Lund, Sweden.
Alteco Medical AB Fundamentals Summary
| ALTE fundamental statistics | |
|---|---|
| Market cap | SEK 26.80m |
| Earnings (TTM) | -SEK 6.51m |
| Revenue (TTM) | SEK 2.94m |
9.1x
P/S Ratio-4.1x
P/E RatioIs ALTE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALTE income statement (TTM) | |
|---|---|
| Revenue | SEK 2.94m |
| Cost of Revenue | SEK 1.71m |
| Gross Profit | SEK 1.24m |
| Other Expenses | SEK 7.74m |
| Earnings | -SEK 6.51m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 12, 2025
| Earnings per share (EPS) | -0.061 |
| Gross Margin | 42.02% |
| Net Profit Margin | -221.25% |
| Debt/Equity Ratio | 2.5% |
How did ALTE perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/07 07:53 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Alteco Medical AB is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.